Eosinophils and Lung Cancer: From Bench to Bedside
Open Access
- 3 May 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (9) , 5066
Abstract
Eosinophils are rare, multifunctional granulocytes. Their growth, survival, and tissue migration mainly depend on interleukin (IL)-5 in physiological conditions and on IL-5 and IL-33 in inflammatory conditions. Preclinical evidence supports an immunological role for eosinophils as innate immune cells and as agents of the adaptive immune response. In addition to these data, several reports show a link between the outcomes of patients treated with immune checkpoint inhibitors (ICI) for advanced cancers and blood eosinophilia. In this review, we present, in the context of non-small cell lung cancer (NSCLC), the biological properties of eosinophils and their roles in homeostatic and pathological conditions, with a focus on their pro- and anti-tumorigenic effects. We examine the possible explanations for blood eosinophilia during NSCLC treatment with ICI. In particular, we discuss the value of eosinophils as a potential prognostic and predictive biomarker, highlighting the need for stronger clinical data. Finally, we conclude with perspectives on clinical and translational research topics on this subject.Keywords
This publication has 92 references indexed in Scilit:
- Pattern‐recognition receptors in human eosinophilsImmunology, 2012
- GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell ProliferationThe Journal of Immunology, 2011
- Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose HomeostasisScience, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cytokine reporter mice in immunological research: perspectives and lessons learnedImmunology, 2010
- Temporal Changes in Myeloid Cells in the Cervix during Pregnancy and ParturitionThe Journal of Immunology, 2009
- Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitorJournal of Experimental Medicine, 2008
- Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM productionJournal of Leukocyte Biology, 2008
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985